STAT+: Why is MoonLake Immunotherapeutics scared of releasing data on its drug candidate?

Summary

STAT News raises concerns about MoonLake Immunotherapeutics' reluctance to release data on its drug candidate, suggesting potential issues with trial results. The article implies that strong clinical data is typically disclosed by biotech companies.